Audicin, a Helsinki-headquartered startup specializing in patent-pending audio treatments for nervous system regulation, announced the successful closure of a €520K pre-seed funding round. The investment round attracted notable investors, including Petteri Lahtela and Virpi Tuomivaara, co-founders of ŌURA Health, alongside other competence-based angel investors. The company’s innovative audio treatments are designed to deliver the benefits of mindfulness without distraction, seamlessly integrating wellness into daily routines. Audicin plans to use the funds to accelerate its go-to-market activities, focusing on revenue growth and scalability.
Audicin revolutionizes the wellness industry with its patent-pending audio treatments designed for nervous system regulation. Founded in 2022, Audicin’s innovative approach combines scientific research and music composition to create audio experiences that promote mental and physiological well-being. The Audicin app offers a range of carefully curated musical journeys aimed at enhancing focus, creativity, relaxation, mood, and sleep. By integrating these treatments into everyday activities, Audicin helps users combat stress, insomnia, and productivity challenges without the need for traditional mindfulness practices or training.
”It is absolutely amazing how the Audicin team combines a deeply scientific approach with the way of composing music to create real masterpieces that have transformative effects on both physiological and mental level. I have used the Oura ring to measure my body responses when using Audicin on different occasions. It has been absolutely amazing to see how it enables me to focus while working and to significantly increase the depth of relaxation while resting during the day. The HRV increase during naps and relaxation has been by far the biggest with Audicin compared to any other method,” comments Petteri Lahtela, Co-founder Oura Health, Audicin investor.
Audicin’s innovative audio treatments deliver the proven benefits of mindfulness without distraction or the need for breathing exercises or training. In just minutes, Audicin sets a dysregulated nervous system on the road to recovery. Audicin’s universal patent pending method is built by music & brain specialists, supercharged by sound engineering. The Audicin app includes carefully curated musical journeys for 24/7 nervous system balance related to work, focus, creativity, mood boost, commute, relaxation and sleep. By seamlessly integrating wellness into our daily routines, Audicin’s solution effectively combats stress, insomnia, mind wandering, productivity paralysis, and the many symptoms that arise from the everyday overstimulation of the nervous system.
Audicin has swiftly gained traction, culminating in the launch of its iOS and Android apps and successful pilot programs with paying customers. After positive piloting experiences on the lucrative U.S. market, Audicin is primed for aggressive go-to-market activities, bolstered by its recent funding.
Laura Avonius, Founder and CEO of Audicin, expressed her elation at the successful funding round, stating, “We raised more than planned, kept our valuation on target, attracted highly competent investors, and launched our product ahead of completion in a challenging economic environment. I couldn’t be happier! Big thanks to our customers, users, investors, and team members.”
As Audicin sets its sights on revenue growth and scalability, the company remains dedicated to its mission of democratizing access to wellbeing, fostering healthier, more resilient communities worldwide.
Click to read more funding news.
Read the orginal article: https://arcticstartup.com/audicin-raises-e520k-pre-seed/
